-
Cervical Cancer Screening Guideline UpdatedA new version of the American Cancer Society's cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method.
by Anna Azvolinsky
-
Support Grows for Making Transfusions a Part of HospiceBlood cancer patients have low rates of enrollment in hospice. One barrier to enrollment is that many hospices do not provide blood transfusions.
by Jon Kelvey
-
Facts and Stats
A Brief History of Checkpoint InhibitorsThe advent of checkpoint inhibitors has broadened the range of cancer patients able to take advantage of immunotherapy.
by Bradley Jones
-
From the Editor-in-Chief
Measuring a Cancer Drug’s EffectivenessSurrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?
by William G. Nelson, MD, PhD
-
Anal Cancer Diagnoses and Deaths Are Rising in the U.S.Study underscores importance of early detection and prevention.
by Jane Langille
-
Forward Look
Cancer Treatments and Antioxidant Supplements Can Be a Bad MixChristine Ambrosone on what her research shows.
by Sue Rochman
-
In It for the Long HaulDoctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.
by Kate Yandell
-
Forward Look
Here Come the BiosimilarsAs patents expire on biologic drugs, cancer patients get new options.
by Stephen Ornes
-
Forward Look
More Treatments Approved for Metastatic Breast CancerTargeted therapy approvals increase options and hope for some patients.
by Cameron Walker
-
Forward Look
Cancer Death Rate Decline Makes HeadlinesExperts say it's necessary to look behind the statistics.
by Delia O’Hara
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
